[{"data": {"name": "Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "F. Lo-Coco", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://pdfs.semanticscholar.org/b70b/343a069e71454c423be3e5dc927cceb62dcf.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Society of Hematology", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1182/blood-2004-04-1550", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCEcvrWEBpVJY-CThkYC1e4v79F-CDG2MsJrwjyvt-CRbRPs4Cb4QtT", "propertyID": "ISCC"}], "datePublished": "2004-10-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]